143 related articles for article (PubMed ID: 32242287)
1. Reticulin staining pattern in the differential diagnosis of benign parathyroid lesions.
Kuşku Çabuk F; Sar M; Canoğlu D; Dural C; Güneş ME
J Endocrinol Invest; 2020 Nov; 43(11):1571-1576. PubMed ID: 32242287
[TBL] [Abstract][Full Text] [Related]
2. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
3. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
4. Rapid Reticulin Fiber Staining Method is Helpful for the Diagnosis of Pituitary Adenoma in Frozen Section.
Noh S; Kim SH; Cho NH; Kim SH
Endocr Pathol; 2015 May; 26(2):178-84. PubMed ID: 25952080
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
6. Peroperative evaluation of parathyroid glands using fat stain on frozen sections. Advantages and limitations.
Farnebo LO; von Unge H
Acta Chir Scand Suppl; 1984; 520():17-24. PubMed ID: 6209877
[TBL] [Abstract][Full Text] [Related]
7. Chief cell intracytoplasmic fat used to evaluate parathyroid disease by frozen section.
King DT; Hirose FM
Arch Pathol Lab Med; 1979 Nov; 103(12):609-12. PubMed ID: 583119
[TBL] [Abstract][Full Text] [Related]
8. The presence of erythropoietin receptor in parathyroid cells.
Oztürk M; Ustek D; Akbas F; Kösem M; Abaci N; Alagöl F; Oztürk G; Kotan C
J Endocrinol Invest; 2007 Dec; 30(11):RC35-7. PubMed ID: 18250608
[TBL] [Abstract][Full Text] [Related]
9. Intracellular lipid droplets in functioning transitional parathyroid oxyphil adenomas. A caveat.
Alpern HD; Roth SI; Olson JE
Arch Surg; 1990 Mar; 125(3):410-1. PubMed ID: 1689566
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonic appearance of adenomatous and hyperplastic parathyroid glands.
Rastad J; Fransson A; Lindgren PG; Johansson H; Ljunghall S; Malmaeus J; Akerström G
Acta Radiol Diagn (Stockh); 1984; 25(6):471-5. PubMed ID: 6151782
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
12. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
13. Significance of AgNOR counts for distinguishing carcinoma from adenoma and hyperplasia in parathyroid gland.
Kanematsu E; Matsui H; Deguchi T; Yamamoto O; Korematsu M; Kobayashi A; Nezasa SI; Yamamoto N; Takeuchi T; Tanaka T; Kawada Y
Hum Pathol; 1997 Apr; 28(4):421-7. PubMed ID: 9104941
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
15. Can we predict expected adenoma weight preoperatively with reference to the correlation of preoperative biochemical tests with parathyroid adenoma weight?
Leong DCW; Lo J; Nguyen H; Ryan S
Asian J Surg; 2020 Jul; 43(7):759-764. PubMed ID: 31699571
[TBL] [Abstract][Full Text] [Related]
16. The sites of hormone storage in normal and diseased parathyroid glands: a silver impregnation and immunohistochemical study.
Pesce C; Tobia F; Carli F; Antoniotti GV
Histopathology; 1989 Aug; 15(2):157-66. PubMed ID: 2476371
[TBL] [Abstract][Full Text] [Related]
17. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
18. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
19. Pathology of the parathyroid glands.
Williams ED
Clin Endocrinol Metab; 1974 Jul; 3(2):285-303. PubMed ID: 4611666
[No Abstract] [Full Text] [Related]
20. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
